DHR · Business segments
Danaher (DHR) revenue by segment
Where Danaher’s revenue comes from, as reported in its SEC filings.
Latest quarter: September 25, 2026
Total revenue on the income statement: $6.55B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| North America | $2.74B | 41.8% |
| High Growth Markets | $2.03B | 30.9% |
| Western Europe | $1.49B | 22.7% |
| Other Developed Markets | $298M | 4.5% |
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| Revenue From Contract With Customer, Measurement, Recurring | $5.4B | 82.4% |
| Revenue From Contract With Customer, Measurement, Nonrecurring | $1.16B | 17.6% |
Revenue by Segment
| Line | Revenue | Share | Operating income | Margin |
|---|---|---|---|---|
| Diagnostics | $2.88B | 44.0% | $614M | 21.3% |
| Life Sciences | $1.86B | 28.5% | $259M | 13.9% |
| Biotechnology | $1.81B | 27.6% | $477M | 26.4% |
Latest year: December 31, 2025
Total revenue on the income statement: $24.57B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| North America | $10.36B | 42.2% |
| High Growth Markets | $7.02B | 28.6% |
| Western Europe | $5.94B | 24.2% |
| Other Developed Markets | $1.25B | 5.1% |
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| Revenue From Contract With Customer, Measurement, Recurring | $20.13B | 81.9% |
| Revenue From Contract With Customer, Measurement, Nonrecurring | $4.44B | 18.1% |
Revenue by Segment
| Line | Revenue | Share | Operating income | Margin |
|---|---|---|---|---|
| Diagnostics | $9.94B | 40.5% | $2.65B | 26.7% |
| Life Sciences | $7.33B | 29.9% | $520M | 7.1% |
| Biotechnology | $7.29B | 29.7% | $1.86B | 25.6% |
Reading notes
Share is each line’s part of that breakdown. Margin is the company’s reported segment operating income divided by that segment’s revenue. Companies define segment profit differently and may re-cut segments over time, so a company’s lines can differ between years. Breakdowns that do not add up to within 5% of reported revenue are left out.